Stage III Breast Cancer Recruiting Phase 1 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02453620Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast CancerTreatment